By Siddhi Mahatole June 26 (Reuters) - The U.S. Food and Drug Administration has approved Viridian Therapeutics' drug to ...

The success of teprotumumab has demonstrated the potential for insulin-like growth factor-1 receptor (IGF-1R) targeted therapy, and several other agents that target IGF-1R are in various stages of ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today ...

Doses of Tepezza are given by an intravenous infusion through a blood vessel in your arm. This infusion is usually given at a hospital, health care provider’s office, or infusion center. Sometimes you ...

One third of the world's population is infected with the Toxoplasma parasite, which can cause ocular toxoplasmosis, an eye ...

Treatment options today can slow disease progression and ease symptoms. Along with medical care, lifestyle adjustments can also make a big difference in your daily comfort and quality of life. Here ...

Allergies, dehydration, medications, and eye diseases are common causes of glassy eyes. Lubricating eye drops, allergy medications, and lifestyle changes can treat smooth, glossy, or watery eyes.

The administration of low-level light therapy before and after cataract surgery relieved symptoms of dry eye, a frequent complication of the procedure. This noninvasive treatment also enhanced the ...

Dry eye disease is a condition that occurs when your eyes do not make enough tears or when your tears dry up too quickly. Tears are essential for keeping the surface of your eyes healthy, comfortable, ...

A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, emphasizing the importance of precise diagnosis and tailored treatment while ...